Clinical Trials

NCT05006404 | ACTIVE_NOT_RECRUITING | NA
51 participants

Autus Valve Pivotal Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2024-02-05
Completion:
2026-08-01
Conditions
  • Congenital Heart Disease
Interventions
  • DEVICE
No Results Yet
NCT04970901 | ACTIVE_NOT_RECRUITING | PHASE1
154 participants

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2022-06-17
Completion:
2027-03-31
Conditions
  • B-Cell Non-Hodgkin Lymphoma
  • Relapsed B-Cell Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
Interventions
  • DRUG
No Results Yet
NCT04915508 | ACTIVE_NOT_RECRUITING | PHASE2
165 participants

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-06-23
Completion:
2026-12-31
Conditions
  • Prostate Adenocarcinoma
  • Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
  • Stage IIIC Prostate Cancer AJCC v8
  • Stage IV Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT04785300 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
20 participants

ALSENLITE: Senolytics for Alzheimer's Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2022-07-06
Completion:
2026-12-31
Conditions
  • Mild Cognitive Impairment
  • Alzheimer Disease
Interventions
  • DRUG
No Results Yet
NCT04719273 | COMPLETED | PHASE2
14 participants

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-01-28
Completion:
2025-03-01
Conditions
  • Refractory Endometrial Adenocarcinoma
  • Refractory Endometrial Carcinoma
  • Refractory Endometrial Clear Cell Adenocarcinoma
  • Refractory Endometrial Endometrioid Adenocarcinoma
  • Refractory Endometrial Mixed Cell Adenocarcinoma
  • Refractory Endometrial Serous Adenocarcinoma
  • Refractory Endometrial Undifferentiated Carcinoma
Interventions
  • DRUG
  • OTHER
  • DIAGNOSTIC_TEST
NCT04692493 | RECRUITING | PHASE3
924 participants

RA-PRO PRAGMATIC TRIAL

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-09-22
Completion:
2029-05-31
Conditions
  • Rheumatoid Arthritis
Interventions
  • DRUG
No Results Yet
NCT04497922 | COMPLETED | NA
100 participants

Virtual White Boards for Patient Satisfaction

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-01-25
Completion:
2021-07-01
Conditions
  • Satisfaction, Patient
  • Covid19
  • Emergencies
  • Satisfaction
  • Information Disclosure
Interventions
  • DEVICE
  • BEHAVIORAL
No Results Yet
NCT04487041 | ACTIVE_NOT_RECRUITING | PHASE4
400 participants

Tfh Dysfunction in HIV and Aging

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2020-10-30
Completion:
2027-04-30
Conditions
  • Human Influenza
Interventions
  • BIOLOGICAL
No Results Yet
NCT04467021 | ACTIVE_NOT_RECRUITING | NA
61 participants

Cancer and Blood Pressure Management, CARISMA Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2020-10-29
Completion:
2026-08-31
Conditions
  • Cardiovascular Disorder
  • Chronic Kidney Disease
  • Metastatic Renal Cell Carcinoma
  • Metastatic Thyroid Gland Medullary Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
  • Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
  • Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
  • Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
Interventions
  • OTHER
No Results Yet
NCT04462406 | ACTIVE_NOT_RECRUITING | PHASE2
150 participants

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-17
Start Date:
2021-02-09
Completion:
2027-01-31
Conditions
  • Advanced Melanoma
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Melanoma of Unknown Primary
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIID Cutaneous Melanoma AJCC v8
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8
  • Unresectable Acral Lentiginous Melanoma
  • Unresectable Melanoma
  • Unresectable Mucosal Melanoma
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page